262 related articles for article (PubMed ID: 20200288)
21. Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.
Al Mosaid A; Sullivan DJ; Polacheck I; Shaheen FA; Soliman O; Al Hedaithy S; Al Thawad S; Kabadaya M; Coleman DC
J Clin Microbiol; 2005 Aug; 43(8):4026-36. PubMed ID: 16081946
[TBL] [Abstract][Full Text] [Related]
22. AFLP genotyping of Candida metapsilosis clinical isolates: evidence for recombination.
Hensgens LA; Tavanti A; Mogavero S; Ghelardi E; Senesi S
Fungal Genet Biol; 2009 Oct; 46(10):750-8. PubMed ID: 19559094
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.
Mokaddas E; Khan ZU; Ahmad S
Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881
[TBL] [Abstract][Full Text] [Related]
24. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
Pinjon E; Jackson CJ; Kelly SL; Sanglard D; Moran G; Coleman DC; Sullivan DJ
Antimicrob Agents Chemother; 2005 Apr; 49(4):1312-8. PubMed ID: 15793103
[TBL] [Abstract][Full Text] [Related]
25. Comparison of phenotypic methods for the identification of Candida dubliniensis.
Pasligh J; Radecke C; Fleischhacker M; Ruhnke M
J Microbiol Immunol Infect; 2010 Apr; 43(2):147-54. PubMed ID: 20457432
[TBL] [Abstract][Full Text] [Related]
26. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
27. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients.
Badiee P; Alborzi A; Davarpanah MA; Shakiba E
Arch Iran Med; 2010 Jul; 13(4):282-7. PubMed ID: 20597560
[TBL] [Abstract][Full Text] [Related]
28. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait.
Ahmad S; Khan Z; Mokaddas E; Khan ZU
J Med Microbiol; 2004 Jul; 53(Pt 7):633-637. PubMed ID: 15184534
[TBL] [Abstract][Full Text] [Related]
29. Candida dubliniensis at a cancer center.
Sebti A; Kiehn TE; Perlin D; Chaturvedi V; Wong M; Doney A; Park S; Sepkowitz KA
Clin Infect Dis; 2001 Apr; 32(7):1034-8. PubMed ID: 11264031
[TBL] [Abstract][Full Text] [Related]
30. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.
Moran G; Sullivan D; Morschhäuser J; Coleman D
Antimicrob Agents Chemother; 2002 Sep; 46(9):2829-41. PubMed ID: 12183235
[TBL] [Abstract][Full Text] [Related]
31. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.
Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937
[TBL] [Abstract][Full Text] [Related]
32. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected and non-infected patients and in a yeast culture collection.
Faggi E; Pini G; Campisi E; Martinelli C; Difonzo E
Mycoses; 2005 May; 48(3):211-5. PubMed ID: 15842340
[TBL] [Abstract][Full Text] [Related]
33. Isolation of Candida dubliniensis in denture stomatitis.
Marcos-Arias C; Vicente JL; Sahand IH; Eguia A; De-Juan A; Madariaga L; Aguirre JM; Eraso E; Quindós G
Arch Oral Biol; 2009 Feb; 54(2):127-31. PubMed ID: 18950745
[TBL] [Abstract][Full Text] [Related]
34. Candida fermentati from HIV patients in Chennai, South India.
Umamaheswari K; Menon T
Int J Infect Dis; 2008 Nov; 12(6):e153-4. PubMed ID: 18650108
[No Abstract] [Full Text] [Related]
35. Identification of Candida dubliniensis in a diagnostic microbiology laboratory.
Momani OM; Qaddoomi A
East Mediterr Health J; 2005 May; 11(3):366-71. PubMed ID: 16602455
[TBL] [Abstract][Full Text] [Related]
36. MDR1-mediated drug resistance in Candida dubliniensis.
Wirsching S; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
[TBL] [Abstract][Full Text] [Related]
37. CARE-2 fingerprinting of Candida albicans isolates.
Morschhäuser J; Staib P; Köhler G
Methods Mol Med; 2005; 118():27-34. PubMed ID: 15888932
[TBL] [Abstract][Full Text] [Related]
38. Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.
Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
PLoS One; 2017; 12(4):e0175269. PubMed ID: 28380072
[TBL] [Abstract][Full Text] [Related]
39. Detection of Candida dubliniensis in Venezuela.
Hartung de Capriles C; Mata-Essayag S; Pérez C; Colella MT; Roselló A; Olaizola C; Abate SM
Mycopathologia; 2005 Oct; 160(3):227-34. PubMed ID: 16205971
[TBL] [Abstract][Full Text] [Related]
40. Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis.
Asadzadeh M; Ahmad S; Hagen F; Meis JF; Al-Sweih N; Khan Z
PLoS One; 2015; 10(11):e0142880. PubMed ID: 26580965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
